The assembly and stability of MHC class II-(αβ)2 superdimers

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2307-2316

  Schafer, Peter H ^a,b   Malapati, Sunil ^a   Hanfelt, Kimberly K ^a   Pierce, Susan K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CROSS LINKING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTOR BINDING; X RAY CRYSTALLOGRAPHY;

ANIMALS; B-LYMPHOCYTES; CELL MEMBRANE; CROSS-LINKING REAGENTS; DIMERIZATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYDROGEN-ION CONCENTRATION; LYMPHOMA, B-CELL; MACROMOLECULAR SUBSTANCES; MICE; MOLECULAR WEIGHT; PROTEIN DENATURATION; SODIUM DODECYL SULFATE; TEMPERATURE; TUMOR CELLS, CULTURED;

EID: 0032168660     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
2. Owen, M. J., A.-M. Kissonerghis, H. F. Lodish, and M. J. Crumpton. 1981. Biosynthesis and maturation of HLA-DR antigens in vivo. J. Biol. Chem. 256:8987.
3. Mathis, D. J., C. O. Benoist, V. E. William II, M. R. Kanter, and H. O. McDevitt. 1983. The murine Eα immune response gene. Cell 32:745.
4. Mengle-Gaw, L., and H. O. McDevitt. 1983. Isolation and characterization of a cDNA clone for the murine I-Eβ polypeptide chain. Proc. Natl. Acad. Sci. USA 80:7621.
5. Roche, P. A., M. S. Marks, and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392.
6. Lamb, C. A., and P. Cresswell. 1992. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148:3478.
7. Roche, P. A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345:615.
8. Teyton, L., D. O'Sullivan, P. W. Dickson, V. Lotteau, A. Sette, P. Fink, and P. A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348:39.
9. Busch, R., I. Cloutier, R. P. Sekaly, and G. J. Hammerling. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15:418.
10. Anderson, M., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
11. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S. L. Schmid, V. Quaranta, and P. A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600.
12. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707.
13. Xu, X., W. Song, H. Cho, Y. Qiu, and S. K. Pierce. 1995. Intracellular transport of invariant chain-MHC class II complexes to the peptide-loading compartment. J. Immunol. 155:2984.
14. Amigorena, S., P. Webster, J. Drake, J. Newcomb, P. Cresswell, and I. Mellman. 1995. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med. 181:1729.
15. Morton, P. A., M. L. Zachais, K. S. Giacoletto, J. A. Manning, and B. D. Schwartz. 1995. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J. Immunol. 154:137.
16. Roche, P. A., and P. Cresswell. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA 88:3150.
17. Neefjes, J. J., and H. L. Ploegh. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO J. 11:411.
18. Maric, M. A., M. D. Taylor, and J. S. Blum. 1994. Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA 91:2171.
19. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
20. Sadegh-Nasseri, S., and R. N. Germain. 1992. How MHC class II molecules work: peptide-dependent completion of protein folding. Immunol. Today 13:43.
21. Springer, T. A., J. F. Kaufman, L. A. Siddoway, D. L. Mann, and S. L. Strominger. 1977. Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association. J. Biol. Chem. 252:6201.
22. Dornmair, K., B. Rothenhausler, and H. M. McConnell. 1989. Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harbor Symp. Quant. Biol. 54:409.
23. Sadegh-Nasseri, S., and R. N. Germain. 1991. A role for peptide in determining MHC-class II structure. Nature 353:167.
24. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
25. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
26. Jardetzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, Y. Chi, C. Stauffacher, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711.
27. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
28. Kim, J. R., R. J. Urban, J. L. Strominger, and D. C. Wiley. 1994. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule, HLA-DR1. Science 266:1870.
29. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
30. Stern, L. J., J. H. Brown, R. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
31. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
32. Konig, R., L.-Y. Huang, and R. N. Germain. 1992. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356:796.
33. 2 domain of HLA-DR molecules. Nature 356:799.
34. + T cells. J. Immunol. 150:5299.
35. Konig, R., X. Shen, and R. N. Germain. 1995. Involvement of both major histocompatibility class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779.
36. Schafer, P. H., S. K. Pierce, and T. S. Jardetzky. 1995. The structure of MHC class II: role for the dimer of dimers. Semin. Immunol. 7:389.
37. Bentley, G. A., G. Boulot, K. Karjalainen, and R. A. Mariuzza. 1995. Crystal structure of the β chain of a T cell antigen receptor. Science 267:1984.
38. α domain of a T cell antigen receptor. Science 270:1821.
39. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274:209.
40. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
41. Reich, Z., J. J. Boniface, D. S. Lyons, N. Borochov, E. J. Wachtel, and M. M. Davis. 1997. Ligand-specific oligomerization of T-cell receptor molecules. Nature 387:617.
42. Sakihama, T., A. Smolyar, and E. L. Reinherz. 1995. Molecular recognition of antigen involves lattice formation between CD4, MHC class II, and TCR molecules. Immunol. Today 16:581.
43. Schafer, P. H., and S. K. Pierce. 1994. Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity 1:699.
44. Roucard, C., F. Garban, N. A. Mooney, D. J. Charron, and M. L. Ericson. 1996. Conformation of human leukocyte antigen class II molecules. J. Biol. Chem. 271:13993.
45. Cherry, R. J., K. M. Wilson, K. Triantafilou, P. O'Toole, I. E. G. Morrison, P. R. Smith, and N. Fernandez. 1998. Detection of dimers of dimers of human leukocyte antigen (HLA)-DR on the surface of living cells by single-particle fluorescence imaging. J. Cell Biol. 140:71.
46. Ozato, K., N. Mayer, and D. H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia-antigens. J. Immunol. 124:533.
47. Lerner, E. A., L. A. Matis, C. A. Janeway, P. P. Jones, R. H. Schwartz, and D. B. Murphy. 1980. Monoclonal antibody against an Ir gene product? J. Exp. Med. 152:1085.
48. Quill, H., R. H. Schwartz, and L. H. Gilmcher. 1986. Ekβ mutant antigen-presenting cell lines expressing altered Akα molecules. J. Immunol. 136:3351.
49. Kozono, H., D. Parker, J. White, P. Marrack, and J. Kappler. 1995. Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity 3:187.
50. Barber, L. D., and R. I. Lechler. 1991. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules. J. Immunol. 147:2346.
51. Griffith, I. J., F. M. Carland, and L. H. Glimcher. 1987. Alteration of a non-polymorphic residue in a class II Eb gene eliminates an antibody-defined epitope without affecting T cell recognition. J. Immunol. 138:4480.
52. Pennell, C. A., L. W. Arnold, P. M. Lutz, N. J. LoCasio, P. B. Willoughby, and G. Haughton. 1985. Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B cell lymphomas: etiological implications. Proc. Natl. Acad. Sci. USA 82:3799.
53. Lakey, E. K., E. Margoliash, F. W. Fitch, and S. K. Pierce. 1986. Role of L3T4 and Ia in the heteroclitic response of T cells to cytochrome c. J. Immunol. 136: 3933.
54. Srinivasan, M., and S. K. Pierce. 1990. Isolation of a functional antigen-Ia complex. Proc. Natl. Acad. Sci. USA 87:919.
55. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027.
56. Schafer, P. H., J. M. Green, S. Malapati, L. Gu, and S. K. Pierce. 1996. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR. J. Immunol. 157:5487.
57. Cleveland, D. W., S. G. Fischer, M. W. Kirschner, and U. K. Laemmli. 1977. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J. Biol. Chem. 252:1102.
58. Lamb, R. A., and P. W. Choppin. 1977. The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of peptides. Virology 81:382.
59. Srinivasan, M., S. Z. Domanico, P. T. P. Kaumaya, and S. K. Pierce. 1993. Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response. Eur. J. Immunol. 23:1011.
60. Cristau, B., P. H. Schafer, and S. K. Pierce. 1994. Heat shock enhances antigen processing and accelerates the formation of compact class II αβ dimers. J. Immunol. 152:1546.
61. 35S]dithiobis(succinimidyl propionate). J. Mol. Biol. 104:243.
62. Kornblatt, J. A., and D. F. Lake. 1980. Cross-linking of cytochrome oxidase subunits with difluorodinitrobenzene. Can. J. Biochem. 58:219.
63. Cosson, P., and J. S. Bonifacino. 1992. Role of transmembrane domain interactions in the assembly of class II MHC molecules. Science 258:659.
64. Runnels, H. A., J. C. Moore, and P. E. Jensen. 1996. A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J. Exp. Med. 183:127.
65. Boniface, J. J., D. S. Lyons, D. A. Wettstein, N. L. Allbritton, and M. M. Davis. 1996. Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. J. Exp. Med. 183:119.
66. Konig, R., S. Fleury, and R. N. Germain. 1996. The structural basis of CD4-MHC class II interactions: coreceptor contributions to T cell receptor antigen recognition and oligomerization-dependent signal transduction. Curr. Top. Microbiol. Immunol. 205:19.
67. Nag, B., D. Passmore, T. Kendrick, H. Bhayani, and S. D. Sharma. 1992. N-linked oligosaccharides of murine major histocompatibility complex class II molecule: role in antigenic peptide binding, T cell recognition, and clonal nonresponsiveness. J. Biol. Chem. 267:22624.
68. Sakihama, T., A. Smolyar, and E. L. Reinherz. 1995. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA 92:6444.
69. Goodman, S., T. Sawada, J. A. Barbosa, B. Cole, R. Pergolizzi, J. Silver, E. Mellins, and M. Y. Chang. 1995. Mutational analysis of two DRα residues involved in dimers of HLA-DR molecules. J. Immunol. 155:1210.